Markets:

Overview

News

Currencies

International

Treasuries

HEALTHCARE (NY:XLV)

144.15 -2.09 (-1.43%)

Streaming Delayed Price Updated: 1:33 PM EDT, Apr 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about HEALTHCARE

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

42 43 Next >

Stocks At A Major Crossroads. This Chart Is The Key. ↗

September 06, 2023

A look at the current five most important charts.

Via Talk Markets

Blame Apple And Microsoft For Dragging Down S&P 500?

September 06, 2023

Tech giants Apple and Microsoft declined in August on weak revenue guidance, but Federal Reserve rate hikes are also playing a role in a broad-market pullback.

Via MarketBeat

Topics Economy Stocks

Healthcare Portfolio: A Mixed Market Looking for Value ↗

September 05, 2023

Many healthcare stocks may be defensive in nature but if you are overweight the basic plays like the XLV or biotech funds like the Fidelity Biotechnology Fund you are trailing the market over the past...

Via Talk Markets

The 3 Most Promising Healthcare Stocks to Own Now ↗

September 01, 2023

These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products.

Via InvestorPlace

How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?

September 01, 2023

Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.

Via MarketBeat

Topics Economy

Bonds Over Earnings? ↗

August 03, 2023

Via Talk Markets

Developing Your Uniqueness As A Trader ↗

July 15, 2023

Via Talk Markets

Does A 7.6% Dividend Make Walgreens A Better Buy Than CVS?

August 29, 2023

These two high-potential healthcare names bring a rare opportunity for investors to gain some exposure to quality businesses trading at a discount to industry

Via MarketBeat

Protect Your Portfolio and Rotate Into Healthcare Stocks Now ↗

August 25, 2023

Healthcare stocks are starting to outperform as tech stocks start to falter. Making a rotation now can help you survive what's to come.

Via InvestorPlace

Energy Holds Above Their 50-DMAs ↗

August 22, 2023

This month has seen a material decline in the percentage of stocks trading above their respective 50-DMAs.

Via Talk Markets

Large Cap Biopharmaceuticals Performance 2023 YTD: Mixed Results But Lilly Is A Big Winner ↗

August 21, 2023

Biotech stocks are in a bear market since the IBB hit $177.37 in 2021 and is down 7.84% over five years.

Via Talk Markets

Beyond The Hustle: Embracing Ancient Chinese Wisdom To Combat Modern Day Burnout ↗

August 17, 2023

In our modern, high-speed society, many find themselves exhausted in the relentless chase for achievement. Yet, a concept from ancient China that dates back 2,000 years might offer a path to...

Via Benzinga

Your Mid-August Market Update: Selling And Scanning ↗

August 15, 2023

Stock indexes slid 1% today with bonds closing weaker, down at 2023 lows as interest rates traded up to highs in 2023.

Via Talk Markets

Topics Bonds

US Retail Sales Accelerate, On Track For The Best Streak In Over A Year: Sector ETFs To Watch ↗

August 14, 2023

Via Benzinga

Topics ETFs

Buy Merck (MRK) Stock Now to Ride a Wave Higher in Healthcare ↗

August 11, 2023

Healthcare stocks are starting to shine in 2023 after bottoming out and MRK stock is particularly appealing. Here's why.

Via InvestorPlace

Investors Go Into Risk-Off Mode For The Fund-Flows Week ↗

August 11, 2023

Investors were net purchasers of fund assets (including those of conventional funds and ETFs) for the third week in four, injecting a net $10.8 billion.

Via Talk Markets

Buckle Up! 3 Healthcare Stocks Set to Soar to New Heights ↗

August 03, 2023

Individual healthcare stocks have been trading really well, even as the sector is treading water. Here are three to know about now.

Via InvestorPlace

The Good, The Flat, And The Volatile: Sorting Through The Sideways Market ↗

August 01, 2023

Via Talk Markets

Key ETF Performance Through July 2023 ↗

August 01, 2023

The S&P 500-tracking ETF finished July up 3.27%, leaving it up 20.62% YTD on a total return basis.

Via Talk Markets

Here's Exactly How I'll Make Over $18,000 in Dividend Income This Year ↗

July 30, 2023

Even investments with lower yields can generate significant dividend income.

Via The Motley Fool

Tech Stocks Still Lead Market By Wide Margin This Year ↗

July 27, 2023

This year’s rally in US stocks continues to rely heavily on a handful of red-hot sectors, based on a review of ETFs.

Via Talk Markets

Pandemic Shadows Lift As US Consumer Confidence Soars To 2-Year High ↗

July 25, 2023

Via Benzinga

Big Weeks Ahead For MedTech And Life Science Stocks ↗

July 24, 2023

It’s a big week for earnings that may change the trajectory of the rally but more than likely will continue the rotation into different sectors.

Via Talk Markets

Jefferies Financial, Apollo Global Management And A Major Sector ETF: CNBC's 'Final Trades' ↗

July 24, 2023

On CNBC’s "Halftime Report Final Trades," Shannon Saccocia of NB Private Wealth said to watch for the health-care sector, naming Health Care Select Sector SPDR Fund (NYSE: XLV)

Via Benzinga

Correction Bottom Searching ↗

July 23, 2023

Big picture, that‘s what we can expect in stocks over the coming weeks, making for a traders‘ market as select sectors are more richly valued than others.

Via Talk Markets

Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗

July 17, 2023

Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%.

Via Talk Markets

2023 Midyear Review Of Index ETFs And Smart Beta Strategies & A Tribute To Harry Markowitz ↗

July 11, 2023

A review and analysis of the first 6 months of 2023 using benchmark ETFs, Sector ETFs, and Smart Beta ETFs and what is likely to follow next.

Via Talk Markets

Biogen Shares Fall After FDA Approval Of Alzheimer's Drug Leqembi

July 10, 2023

Biogen's shares decline after approval of Alzheimer's treatment Leqembi, which modestly slows cognitive decline. Analysts see hurdles to the rollout.

Via MarketBeat

Thoughts For Thursday: Back From The Holiday With Caution ↗

July 06, 2023

Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China.

Via Talk Markets

$1 Billion Deal For Moderna To Expand Product Pipeline in China

July 06, 2023

Moderna is looking to diversify its falling U.S. product line, a $1 billion investment in China may act as the catalyst pushing the company's valuation higher

Via MarketBeat

Topics ETFs Economy

< Previous 1 2

...

25 26 27 28 29 30 31 32 33

...

42 43 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.